Document 0246 DOCN M9460246 TI Circulating HIV-1-infected cell burden from seroconversion to AIDS: importance of postseroconversion viral load on disease course. DT 9404 AU Lee TH; Sheppard HW; Reis M; Dondero D; Osmond D; Busch MP; Irwin Memorial Blood Centers, San Francisco, CA 94118-4496. SO J Acquir Immune Defic Syndr. 1994 Apr;7(4):381-8. Unique Identifier : AIDSLINE MED/94180313 AB The purpose of this study was to characterize quantitative changes in circulating infected cells over the natural history of human immunodeficiency virus (HIV) disease in relation to clinical/immunological outcome. HIV-1 gag DNA polymerase chain reaction (PCR) and peripheral blood mononuclear cell (PBMC) co-cultures were performed on limiting dilutions of cryopreserved PBMC from specimens collected at enrollment and after 5 years of follow-up from nine seropositive subjects classified as rapid progressors, nine intermediate progressors, and 10 nonprogressors. Limiting dilution PCR was also performed on serial pre/postseroconversion specimens from 18 seroconvertors. By quantitative DNA PCR analysis, the infected cell burden was significantly higher at enrollment in the RP [mean of 330 PCR units (PCRU)/10(6) PBMCs] than in the IP (160 PCRU/10(6) PBMCs) and NP (73 PCRU/10(6) PBMCs) groups (p = 0.05). When results were analyzed on an individual level with proportional hazard regression, baseline PCRU (p = 0.05) and CD4 slope (p = 0.0007) were significantly associated with developing acquired immune deficiency syndrome (AIDS) in 5 years, but baseline tissue culture infectious units (TCIU) was not. The increase in PCR-positive cells after 5 years was modest in all three groups (two- to fivefold), whereas the proportion of PCR-positive cells that yielded virus in culture increased significantly (21- to 31-fold) over time in all three groups. Infected cell burden in postseroconversion specimens was relatively stable within each subject, but varied greatly (from 1.6 to 1,024 PCRU/10(6) PBMCs) among subjects.(ABSTRACT TRUNCATED AT 250 WORDS) DE Acquired Immunodeficiency Syndrome/IMMUNOLOGY/*MICROBIOLOGY Cohort Studies Cryopreservation DNA, Viral/BLOOD Human HIV Seropositivity/IMMUNOLOGY/*MICROBIOLOGY HIV-1/GENETICS/IMMUNOLOGY/*PHYSIOLOGY Leukocyte Count Leukocytes, Mononuclear/*MICROBIOLOGY Longitudinal Studies Male Polymerase Chain Reaction Proportional Hazards Models Proviruses/GENETICS/IMMUNOLOGY/PHYSIOLOGY Reproducibility of Results Support, U.S. Gov't, P.H.S. T4 Lymphocytes Viremia/IMMUNOLOGY/MICROBIOLOGY JOURNAL ARTICLE SOURCE: National Library of Medicine. NOTICE: This material may be protected by Copyright Law (Title 17, U.S.Code).